Abstract | INTRODUCTION: METHODS AND RESULTS: CONCLUSIONS: Our findings establish an important link between inflammatory cytokine gene expression, interstitial fibrosis and myocardial electrical activation delays during premature excitation and provide insight into the mechanisms by which mineralocorticoid receptor antagonism may prevent development of an arrhythmogenic ventricular substrate in systolic heart failure.
|
Authors | Christine Tanaka Esposito, Subha Varahan, Darwin Jeyaraj, Yuan Lu, Bruce S Stambler |
Journal | Journal of cardiovascular electrophysiology
(J Cardiovasc Electrophysiol)
Vol. 24
Issue 7
Pg. 806-12
(Jul 2013)
ISSN: 1540-8167 [Electronic] United States |
PMID | 23489714
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2013 Wiley Periodicals, Inc. |
Chemical References |
- Mineralocorticoid Receptor Antagonists
- Spironolactone
|
Topics |
- Animals
- Arrhythmias, Cardiac
(complications, prevention & control)
- Dogs
- Electrophysiological Phenomena
- Fibrosis
(complications, prevention & control)
- Heart Failure
(drug therapy, etiology)
- Heart Ventricles
(physiopathology)
- Inflammation
(complications, prevention & control)
- Mineralocorticoid Receptor Antagonists
(therapeutic use)
- Myocardium
(pathology)
- Spironolactone
(therapeutic use)
- Ventricular Dysfunction
(complications, prevention & control)
|